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ABSTRACT
M
any receptors on natural killer (NK) cells recognize
major histocompatibility complex class I molecules
in order to monitor unhealthy tissues, such as cells
infected with viruses, and some tumors. Genes encoding
families of NK receptors and related sequences are organized
into two main clusters in humans: the natural killer complex
on Chromosome 12p13.1, which encodes C-type lectin
molecules, and the leukocyte receptor complex on
Chromosome 19q13.4, which encodes immunoglobulin
superfamily molecules. The composition of these gene
clusters differs markedly between closely related species,
providing evidence for rapid, lineage-speciﬁc expansions or
contractions of sets of loci. The choice of NK receptor genes
is polarized in the two species most studied, mouse and
human. In mouse, the C-type lectin-related Ly49 gene family
predominates. Conversely, the single Ly49 sequence is a
pseudogene in humans, and the immunoglobulin superfamily
KIR gene family is extensive. These different gene sets encode
proteins that are comparable in function and genetic
diversity, even though they have undergone species-speciﬁc
expansions. Understanding the biological signiﬁcance of this
curious situation may be aided by studying which NK
receptor genes are used in other vertebrates, especially in
relation to species-speciﬁc differences in genes for major
histocompatibility complex class I molecules.
Introduction
Natural killer (NK) cells destroy cells infected with certain
viruses and other intracellular pathogens. They also inﬂuence
immune responses through the release of cytokines. A key
aspect of recognition of appropriate target cells is the
ubiquitously expressed major histocompatibility complex
(MHC) class I molecule, a ligand for which NK cells generally
have multiple receptors [1]. All living jawed vertebrates
studied to date have an adaptive immune system, which,
among other features, rearranges T and B cell receptor gene
segments and exploits antigen presentation provided by
MHC molecules [2,3]. Evolutionarily intermediate species,
which lacked these features, presumably became extinct
through competition with other species possessing a viable
adaptive immune system [4]. A recognition-based MHC
system may have been pivotal to survival of gnathostome
species [3]. NK receptor gene complexes are intimately
associated, both genetically and functionally, with MHC
recognition, and interactions of different combinations of
NK receptors and MHC class I molecules may contribute
signiﬁcantly to selection and disease resistance [4,5].
NK cell receptors come in two forms: inhibitory and
activating. Inhibitory receptors regulate NK actions by
interrupting intracellular activation signals when MHC class I
molecules are correctly expressed [6]. Activating receptors,
some of which bind ligands other than MHC class I molecules,
trigger NK responses to cells with viral, bacterial, or parasitic
infections or to some tumor cells with downregulated MHC
class I molecules [7]. The effector function of each receptor
molecule is determined by the sequence of its
transmembrane region and cytoplasmic tail [8]. Generally,
inhibitory receptors possess an immunoreceptor tyrosine-
based inhibitory motif (ITIM) in their cytoplasmic tails [6],
which decreases activation [9]. Upon stimulation, the ITIM
becomes tyrosine phosphorylated and associates with
intracellular phosphatases such as Src homology 2 (SH2)
domain–containing protein tyrosine phosphatase 1 (SHP1) or
SHP2. SHP1 then dephosphorylates the actin cytoskeleton
regulator, Vav, which blocks actin-dependent activation
signals [9]. In contrast, activating receptors lack ITIMs in their
cytoplasmic tails and often contain charged residues that
facilitate association with adaptor molecules containing
immunoreceptor tyrosine-based activation motifs (ITAMs)
such as DAP12 [10,11]. When activating receptors are
associated with ITAM-containing adaptor molecules, the
adaptor molecules become tyrosine phosphorylated and bind
to kinases, which then interact with Vav and Rac1. The
subsequent molecular cascade leads to actin polymerization
and, consequently, cytotoxicity and/or cytokine release [11].
The ITIM/ITAM paradigm of inhibition/activation is a feature
shared by NK receptors in all species, but it does not apply to
all receptors. The human KIR2DL4 and KIR3DL3 molecules,
for example, have unconventional cytoplasmic tails, and their
mode of action, inhibition or activation, has not been clearly
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stimulatory NK receptors, as well as the proposed pathways
they initiate after ligand binding, are illustrated in Figure 1.
Genes that encode NK receptors are arranged in two main
clusters: the leukocyte receptor complex (LRC) and the
natural killer complex (NKC). The LRC encodes members of
the immunoglobulin superfamily (IgSF), while the NKC
encodes type II transmembrane, C-type lectin-like proteins
[13]. The extent that receptors from each complex are
expressed and utilized varies markedly among species.
Comparing the genomic composition of NK receptor gene
clusters in different species may provide clues to their
evolution. The goal from these studies is to understand the
selective forces, particularly in relation to disease, that have
driven such extreme genomic differences. The diverse
arrangements of genes encoding the MHC ligands of NK
receptors [3] have to be taken into consideration, as NK
receptors and their ligands coevolve.
Human NK Receptor Gene Complexes
The main NK receptors for MHC class I molecules in
humans belong to the IgSF and are encoded in the LRC on
Chromosome 19q13.4 [14]. Of the 45 genes in the LRC, the 30
IgSF receptors can be grouped into several related gene
families based on gene organization, phylogeny, and structure
[15]. These families include the killer cell immunoglobulin-
like receptors (KIRs), leukocyte Ig-like receptors (LILRs; also
called LIRs and ILTs), and the leukocyte-associated Ig-like
receptors (LAIRs). The most centromeric end of the human
LRC contains genes for the platelet glycoprotein VI (GP6),
the natural cytotoxicity-triggering receptor 1 (NCR1; also
called NKp46), and the receptor of the IgA Fc fragment
(FCAR; also called CD89). These proteins are structurally
similar to KIR genes but differ from other loci in the LRC by
interacting with ligands other than MHC class I molecules
[15]. The organization of the human LRC is shown in the
comparative maps of Figure 2.
DOI: 10.1371/journal.pgen.0010027.g001
Figure 1. Examples of Inhibitory and Activating NK Cell Receptors and the Consequences of Their Binding
This figure shows the association of NK receptors with MHC class I molecules and portions of the resulting signaling pathway, as described in the text.
‘‘Src Kinase’’ represents various kinases capable of participating in this interaction, such as Syk and ZAP70. SHP2 (PTPN11) is used in place of SHP1
(PTPN6) in some circumstances, such as associating with KIR2DL4. Symbols show the continuation of the pathway where arrows are not drawn.  ,
negatively charged residue;þ, positively charged residue; AKT1, v-akt murine thymoma viral oncogene homolog 1 (also called RAC); DAG1, dystroglycan
1; FceRI-c, receptor for Fc fragment of IgE, high affinity I, gamma polypeptide; GRB2, growth factor receptor-bound protein 2; INPP5D, inositol
polyphosphate-5-phosphatase, 145kDa (also called SHIP); ITPKB, inositol 1,4,5-trisphosphate 3-kinase B (also called IP3KB); LAT, linker for activation of T
cells; LCP2, lymphocyte cytosolic protein 2 (also called SLP76); P, phosphate group; PAK1, p21/Cdc42/Rac1-activated kinase 1 (STE20 homolog, yeast);
PIK3CG, phosphoinositide-3-kinase, catalytic, gamma polypeptide (also called phosphatidylinositol 3-kinase); PLCG1, phospholipase C, gamma 1; PTEN,
phosphatase and tensin homolog; PTPN6, protein tyrosine phosphatase, nonreceptor type 6 (also called SHP1); RAF, raf protein; RAS, rat sarcoma viral
oncogene homolog; SH3BP2, SH3 domain–binding protein 2; SHC1, SHC (SH2 domain–containing) transforming protein 1; SOS1, son of sevenless
homolog 1; VAV1, vav 1 oncogene; YINM, tyrosine-containing motif (YINM).
DOI: 10.1371/journal.pgen.0010027.g002
Figure 2. Comparative Genomics of Natural Killer Cell Receptor Complexes
This figure, showing LRCs and NKCs in various species, is not drawn to scale; however, the linear arrangement of genes is correct and is aligned vertically
by homology within each region, where possible. Colors indicate genes related by gene organization, structure, and phylogeny. Gray indicates genes
that are not considered NK receptors. White boxes mark pseudogenes. Slash marks represent large distances in the genomic sequence. Some non-NK
receptor genes that are located within this region may not be represented in this figure. A question mark indicates that the gene has been mapped to
the corresponding chromosome, but the specific chromosomal position is not known. An ‘‘X’’ indicates that the gene is not homologous with genes
sharing its vertical alignment. The linear organization of these genes was taken from literature sources as described in the text and from NCBI’s
MapViewer [123]. Similar to in human, only one Ly49 gene has been found in baboon, orangutan, dog, cat, cow, and pig. However, the horse has
multiple Ly49 genes, as does the rodent lineage [96]. The chicken contains two sequences similar to NKC-encoded genes within its MHC [102], again
suggesting an evolutionary relationship between MHC and NK receptor genes. The chicken also possesses multiple genes for Ig domain–containing NK
receptors: the CHIR genes [100]; however, the chicken arrangement is from data assembled from whole genome sequence and will be refined as more
accurate annotation is applied. While the zebrafish contains NK receptors containing Ig or C-type lectin domains, the genomic organization does not
resemble the mammalian pattern of clustering into two main regions [104].
PLoS Genetics | www.plosgenetics.org August 2005 | Volume 1 | Issue 2 | e27 0130PLoS Genetics | www.plosgenetics.org August 2005 | Volume 1 | Issue 2 | e27 0131The key LRC genes directing NK cell recognition of MHC
class I are the KIRs. The KIR gene cluster exhibits marked
differences in gene content and allelic polymorphism
between individual haplotypes [16,17], with up to 17 KIR
genes and pseudogenes arranged tandemly over
approximately 150 kilobases [4]. KIR genes share high
sequence similarity (most are approximately 97% identical),
exhibit marked levels of polymorphism, and evolve rapidly
[18]. This last characteristic may be facilitated by
nonreciprocal crossovers in the tandemly arranged genes,
occasionally generating hybrid loci or expansion/contraction
of gene numbers [18,19]. The KIR gene family in the human/
primate lineage appears to have expanded between 31 and 44
million years ago [13], as dated by the ampliﬁcation of
retroelements of the Alu S subfamily found in the KIR
genomic sequence [17]. KIRs can possess either two (KIR2D)
or three (KIR3D) extracellular Ig domains [15] and comprise
long forms, which contain inhibitory ITIMs, or short forms,
which lack ITIMs and are mostly activating [18]. KIR2DL4,
however, is unique, having both putative inhibitory and
activating properties [12]. In addition to possessing ITIMs in
its cytoplasmic tail, KIR2DL4 has a charged arginine residue
in the transmembrane region that allows association with the
activating accessory protein FceRI-c (FCER1G) [20].
Centromeric to the KIR family is another extensive IgSF
gene family, the LILRs. This family consists of two inverted,
duplicated clusters of six and seven loci, respectively [21]. The
LILR genes show greater intergenic diversity, but less allelic
variation than the KIR family [15]. Unlike KIR genes, there is
little variation in the number of LILR genes on different
haplotypes. Separating the LILR clusters are two LAIR loci,
which sandwich members of the LRC-encoded novel gene
(LENG) family. It has been proposed that the LAIR locus was
duplicated and inverted with the LILR expansion, but the
LRC-encoded novel genes are structurally unrelated to other
Ig-like receptors in the LRC and have a different origin [15].
Additional genes related to those in the LRC are dispersed
further centromeric of the LILR and KIR gene families in the
‘‘extended LRC’’ region. This region includes the receptor
and transporter of the Fc fragment of IgG (FCGRT), which
interestingly may have a common origin with MHC class I
molecules [22], the sialic-acid-binding immunoglobulin-like
lectin (SIGLEC) gene family [23], and the CD66-related gene
family [24]—all of which are related to LILR and KIR
sequences [13].
The other major cluster of NK receptor genes, the human
NKC, is located on Chromosome 12p13.1 [25] and encodes
mainly disulphide-linked dimeric, type II transmembrane
molecules with homology to C-type lectins [26]. NKC-
encoded genes have highly related genomic structures and
are organized into distinct clusters of related genes [26].
Comparative maps of NKCs are shown in Figure 2.
The NKC contains a variety of C-type lectin genes, some of
which are expressed speciﬁcally on NK cells. There is only
one member of the Ly49 gene family, KLRA1 (also called
Ly49L), in humans, as opposed to the multiple homologous
genes encoding MHC class I ligands in rodents [27]. While
KLRA1 is transcribed, a point mutation causes the
production of a nonfunctional molecule [27]. Another gene
family expanded in rodents but with only one human
homolog is KLRB1A (also called NKRP1A). NKRP1A is
expressed only on a subset of NK cells and T cells, as opposed
to all NK cells in rodents [28].
Members of the NKG2 (KLRC) family of molecules dimerize
with the linked, invariant CD94 molecule (KLRD1) on the cell
surface, which as a partner chain provides the appropriate
signaling motifs [29]. Some KLRC-encoded molecules, namely
NKG2A (KLRC1) and NKG2C (KLRC2), signal as a result of
binding to the nonclassical MHC class I molecule HLA-E [30].
This family encodes both inhibitory (NKG2A, NKG2B, and
KLRL1) and activating (NKG2C, NKG2E [KLRC3], and
NKG2H) receptors, some of which, such as NKG2B, NKG2E,
and NKG2H, are products of alternative splicing [26]. When
both inhibitory and activating NKG2 receptors are
coexpressed on the cell surface, the inhibitory molecules
appear to be functionally dominant, which may relate to the
fact that they have a higher-afﬁnity binding [31]. The NKG2
family also contains a unique receptor, NKG2F (KLRC4), that
has a charged residue in the transmembrane region, an ITIM-
like domain, and no C-type lectin–like domain [32]. The
function of this molecule is not known.
NKG2D (KLRK1) shows limited sequence identity to other
NKG2 molecules and is expressed on NK cells, T cells, and
macrophages as a homodimer [26]. For activation, NKG2D
signals by associating with DAP10, a molecule whose Src
homology 2 domain recruits the p85 subunit of
phosphatidylinositol 3-kinase (PI3K) [33,34]. Human NKG2D
binds MHC class I chain-related protein (MIC) A, MICB, and
the UL-16 binding protein (ULBP) family [35].
KLRF1, which is present in humans but not mice [26],
stimulates NK cells upon cross-linking. The inhibitory-
receptor-encoding KLRG1, also called mast cell function–
associated antigen [36], is more centrally located in the
human NKC than in that of the mouse and may have arisen by
gene duplication and chromosomal inversion events [26].
Other NK surface molecules encoded in the human NKC
include the activation-induced C-type lectin (AICL) [37],
lectin-like transcript 1 (CLEC2D; also called OCIL and LLT1)
[38], and CD69 [26]. Genes that encode products not found on
NK cells, which are also located within the NKC, include
alpha-2-macroglobulin (A2M) [26], oxidized low-density
lipoprotein (lectin-like) receptor 1 (OLR1) [39], CLECSF12,
CLEC1, and CLEC2 [40].
Nonhuman Primate NK Receptor Gene Complexes
KIR genes have diverged dramatically between different
primate species, consistent with rapid, species-speciﬁc
expansion of the gene family [41]. In chimpanzees, the seven
KIR genes, of which only three (KIR2DL4, KIR2DL5, and
KIR2DS4) are best reciprocal human orthologs, cover 106
kilobases [41,42]. In the gorilla, 11 KIR genes have been
identiﬁed with two genes being orthologous to human KIRs
[43]. Orangutans, which diverged earlier from humans in the
primate lineage than chimpanzees and gorillas, also have a
species-speciﬁc expanded KIR repertoire [44]. The rhesus
macaque only has ﬁve KIR genes [45,46]. The African green
monkey Chlorocebus sabaeus, another Old World primate more
closely related to rhesus monkeys than to the apes, possesses
multiple KIR genes, namely KIR3DL, KIR2DL4, KIR2DL5, and
KIR3DH, a KIR form found in rhesus and African green
monkeys but not apes, and a hybrid of KIR2DL5 and KIR3DH
[47]. KIR2DL4 is the only orthologous KIR gene found in
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green monkeys. Interestingly, not all gorillas appear to have
KIR2DL4 [43], and it is nonfunctional as a receptor in
orangutans [44]. Table 1 shows, where known, the differences
in gene content of NK receptor genes among various species.
These differences in KIR gene presence accord with
differences in MHC class I gene content among primate
species [48]. For example, HLA-C and its equivalent in other
primate species differentiated from an HLA-B-like ancestor
after divergence of the hominoid and monkey lineages [4,49];
therefore, it is only present in primate species more closely
related to humans. While HLA-C is consistently present in
humans and chimpanzees (the closest relative of humans), it is
absent in approximately half of the orangutan haplotypes,
and when it does occur in orangutans, it resembles an
evolutionary intermediate of human HLA-C [4,44].
Furthermore, Popy-C, the orangutan HLA-C equivalent,
provides only one of the two MHC-C motifs that are used to
control human and chimpanzee NK cells [42,50]. Dimorphism
at amino acid 80 deﬁnes these two groups, where MHC-C1
has Asn80 and MHC-C2 has Lys80. The receptors for the C1
and C2 groups are the inhibitory KIR2DL molecules:
KIR2DL2 and KIR2DL3 interact with C1, while KIR2DL1
interacts with C2 at a higher afﬁnity. From these primate
evolutionary studies, we have learned that the weaker C1–
KIR2DL2/3 interaction arose ﬁrst, and the stronger C2–
KIR2DL1 interaction arose later. Since both C1 and C2
allotypes are represented in all human populations, these
molecules may have complementary functions that enable the
strength of HLA-C-mediated inhibition to be varied. This
situation has implications for MHC/KIR combinations in
disease, as has been evidenced by several recent papers [51–
55]. The association of combinations of C1/C2 types and KIR
alleles with predisposition to preeclampsia suggests other
selection mechanisms [56]. The reciprocal levels of HLA-C1/2
allotypes and their respective KIR ligands in different human
populations is consistent with a balance of advantages and
disadvantages in level of response, presumably depending on
local parasites and environmental conditions.
LILR genes are present in all primates studied, and
although the gene content of this family shows greater
differences between primate species than is observed
throughout the genome, LILR genes are less variable in gene
number between haplotypes than the KIRs. In chimpanzee,
the nine LILR genes border the KIR sequences and are
arranged in two duplicated clusters similar to human [41,57].
Four of these genes are orthologs of human LILR sequences
[57]. The rhesus macaque has ﬁve LILR sequences [41]. Other
NKC genes known to be present in the chimpanzee and
rhesus macaque are orthologs of FCAR and NCR1 [41].
There is limited information on NKC genes in primates.
Members of the NKG2 family and CD94 have been found in
chimpanzees [42], including orthologs for all members except
KLRC2, for which there are two paralogs [58]. Rhesus
Table 1. Presence of NKC and LRC Encoded Genes in Different Species
Category Gene
a Protein
b Function
c Human Chimpanzee Rhesus
Macaque
Orangutan Gorilla Cow Mouse Rat Pig Chicken Horse
NKC Ly49 AI 1( W)1 1 6 3 6 1 6
KLRC1 NKG2A I 1 1 1 1 1 1 1
KLRC1 NKG2C A 1 1 1 1 1
KLRC3 NKG2E A 1 1 1 hybrid of KLRC3 and KLRC4 1
KLRC4 NKG2F A I 1 1 0
KLRK1 NKG2D A C 1 1 1 1 1 1 1 1
KLRD1 CD94 1 1 1 1 1 1
OLR1 LOX1 1 1 1 1 1
CLECSF12 DECTIN1 1 1
CLEC1 1 0
CLEC2 1 1
MICL DCAL2 1 1
CLECSF2 AICL 1 0
KLRF1 1 0
CD69 11 1 1 1 1
CLEC2D LLT1/Clr 1 311
KLRB1 NKRP1 1 1 5 1 1
KLRG1 MAFA I 1 11
LRC LILR LIR, ILT A I 13 9 5 0 0 *
PIR AI 0 0 0 1 0 1
LAIR1 I1 1
LAIR2 1
KIR AI ;15 7 5 ;17 11 4 2 1 Many *
FCAR CD89 A 1 1 1 1 0 1
NCR1 NKp46 A 1 1 1 1 1 1
GP6 1 1
aHUGO gene abbreviation.
bCommon, alternative protein name.
cShows activating (A), inhibitory (I), either (A/I), or co-stimulatory (C) function. An empty box indicates information is not available for that species. The number indicates the approximate number of genes present in that species for a particular
gene family. W indicates a pseudogene.
Asterisk indicates the presence of multiple KIR-ILT hybrid genes in horses [96].
DOI: 10.1371/journal.pgen.0010027.t001
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several splice variants [45]. In the orangutan, orthologs for
human CD94, NKG2A, NKG2D, and NKG2F are present, along
with a hybrid gene combining NKG2C and NKG2E midway
between their expected syntenic positions [44]. Orangutans
also possess a functional homolog of KLRA1 (Ly49L) [44],
which is a pseudogene in humans [27,59]. A single Ly49
sequence, which appears to be functional, has also been
reported in baboons [60].
Rodent NK Receptor Gene Complexes
The mouse LRC is located on Chromosome 7 [15], although
it contains none of the KIR loci that form a cornerstone of
MHC class I recognition in humans. However, two murine
KIR-like sequences have been detected outside the LRC on
the X chromosome [61,62]. There are conﬂicting reports on
the function of one of these murine KIR-like sequences: one
study found that Kir3dl1 (Kirl1) lacks an ITIM and any
residue capable of binding to an activating adaptor molecule
[61], while another reported the presence of two ITIMs in
Kir3dl1 [62]. Surprisingly, the other KIR-like sequence, Kirl2,
is selectively expressed in deﬁned areas of the mouse brain
[63]. The murine LRC contains orthologs of human GP6 [13],
NCR1, RPS9, and LAIR1 [15]. The Pir gene family members
(including Pira1 to Pira11 and Pirb), which share sequence
identity with the human LILRs, are found between Ncr1 and
Rps9, [64]. In addition to sequence similarity, the Pir genes
are arranged into two clusters similar to the LILRs and
encode products that may interact with certain MHC class I
molecules [65]. Genes of the murine LRC broadly display
syntenic homology with the human arrangement apart from
the absence of KIR loci.
In the rat, the LRC is located on Chromosome 1 and
includes an ortholog of murine Pirb, Ncr1 [15], and one KIR
sequence (Kir3dl1) with a potential ITIM [62]. The rat also has
Fcar, which, while also present in humans, was lost in the
mouse lineage [66].
Orthologs of human NKC genes are reported in a syntenic
region of murine Chromosome 6. The gene families are
arranged in a similar order to the human NKC, except for
expansions and interchanges of the C-type lectin related (Clr)
(ortholog of human OCIL) and Nkrp1 (Klrb1) gene families
[26]. Interestingly, the products of these two genetically
intertwined families in mouse interact, suggesting potential
functional advantages for their adjacent gene locations [67].
There are several Klrb1 (Nkrp1) genes in mouse, with Klrb1a,
Klrb1c, and Klrb1f taking activating forms and Klrb1b and
Klrb1d being inhibitory [26]. Members of the NKC-encoded
C-type lectin related gene family have been found as ligands
for Klrb1d and Klrb1f [67].
In the rat, the NKC is located on Chromosome 4. In fact,
the ﬁrst NKC gene discovered in any species was rat Nkrp1
[68,69]. Human, mouse, and rat all share orthologs of CD69
and KLRD1 (CD94); however, there are still many differences
between human and rodent in the gene content of the NKC
[70] (see Figure 2; Table 1).
In contrast to the single human Ly49 locus, the
polymorphic Ly49 gene family in mice contains at least 16
genes and pseudogenes [71], named Ly49a to Ly49q, although
the gene content can differ signiﬁcantly in different mouse
strains [26]. While framework Ly49 genes are present in all
murine haplotypes, the Ly49 gene content between these
framework genes varies at some loci [72], in a similar manner
to what is observed in the human KIR family. These
framework/strain-speciﬁc differences are shown in Figure 3.
The Ly49 molecules have a variety of functions and
expression patterns. Ly49a, Ly49c, Ly49g, and Ly49i contain
ITIMs and act as NK inhibitory receptors when recognizing
MHC class I molecules. Conversely, Ly49d and Ly49h exhibit
activating properties. Ly49e functions in fetal NK cell
development, when other Ly49 molecules are not present
[26]. Ly49q is found on plasmacytoid dendritic cells and not
NK cells [73,74].
In the rat, this family has expanded even further. The most
recent report lists 19 functional rat Ly49 genes and 15
pseudogenes [75]. The rapid expansion of rat Ly49 genes
appears to result from repeated tandem and block gene
duplications, which occurred after species divergence from
the mouse [76], and might be related to the higher number of
MHC class I genes in the rat genome than in the mouse
genome [77].
The Ly49 family in mouse parallels the human KIR both
functionally and genetically [78]. Insight into the evolutionary
drive behind gain or loss of Ly49 loci was provided by
studying the relationship between Ly49 genes and murine
cytomegalovirus (mCMV) [79–82]. When the Ly49h receptor
in mice is not present, is blocked by monoclonal antibody, or
has its pathway interrupted through mutation of the DAP12
molecule, uncontrolled viral replication of mCMV occurs
[80,83], demonstrating that the function of this activating
receptor is essential for mCMV resistance [26]. Ly49h
interacts speciﬁcally with mCMV protein m157 to counteract
DOI: 10.1371/journal.pgen.0010027.g003
Figure 3. Differences in Organization of KIR Genes in Human Haplotypes and Ly49 Genes in Various Mouse Strains
This figure is not drawn to scale, but it illustrates the presence of framework genes and the variable gene content in Ly49 genes in different mouse
strains [72] and KIR sequences in human haplotypes. The vertical arrangement of genes within a family shows allelic relationships. White boxes indicate
known pseudogenes. Please note that while many KIR haplotypes are possible, only a small selection has been shown here.
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an example of the biological arms race [85].
The KLR gene family in mouse contains several members,
including Klrc1, Klrc2, Klrc3, Klrd1, Klri1, and Klri2 [26,86].
Similar to recognition of HLA-E in humans [30], members of
this family recognize the mouse HLA-E functional homolog
H2-T23 [86]. Nkg2d binds minor histocompatibility molecule
H60, the retinoic acid early transcript 1 (Rae-1) family, and
mouse UL-16 binding protein–like transcript 1 (Mult1).
Interestingly, the Mill gene family, the murine functional
equivalent of human MIC genes, which are encoded in the
human MHC class I region and bind NKG2D, are found near
the murine LRC [87]. In mice, Nkg2d is proposed to have
activating properties through association with Dap12 and
Dap10 [34,88]. Human NKG2D cannot associate with DAP12
to produce an activating signal [89]. A direct ortholog of
KLRF1 is not present in the mouse. The murine NKC also
contains Klrg1 and Cd69, and genes other than those encoding
NK receptors—genes such as alpha-2-macroglobulin, Clecsf12,
and Clec2 [26]. Genes encoding three Klrc molecules, Nkg2d,
CD94, Klrb1, and Klrh1 (an inhibitory receptor) have been
reported in rat.
NK Receptor Gene Complexes in Other Species
Since the genomic organization of human and mouse class
I receptors is so polarized, in terms of KIR or Ly49 gene
content, respectively, it is informative to study other species.
The bovine LRC, located on Chromosome 18, includes
activating and inhibitory KIR sequences and an ortholog of
NCR1 [90]. Sequence similarity comparisons between cows
and primates indicate that the multigenic KIR families
expanded independently in the two lineages [91]. Known
genes in the bovine NKC include KLRK1, NKRP1 [92], KLRJ1
[91], and one Ly49 gene [93]. There is a CD69 transcript in
cows as well, but its genetic location is not known [94].
Like humans, the single Ly49 sequence is recapitulated in
cattle [93], domesticated cats, dogs, and pigs [95]. Like rodents
[76], horses show multiple Ly49 genes: ﬁve that encode ITIMs
and one with potentially activating properties [96]. The horse
also has an expansion of a family of KIR-ILT hybrid genes
[96]. These species with both multiple Ly49 and multiple KIR
sequences indicate that the functions of the two sets of MHC
class I ligands can be coordinated. The polarized
arrangement in humans (all KIR) and mice (all Ly49) suggest
that either (1) the existence of both sets within a single
individual poses logistical problems, which have been solved
by disabling one set, or (2) the human and mouse
arrangements are outriders and in most other vertebrates the
functions of both sets of genes synchronize well with each
other. Clearly, the MHC class I/NK ligand gene arrangements
of many other species need to be evaluated.
A gene complex encoding NK receptors in pig is located on
Chromosome 5, with reports of direct orthologs for human
CD69 and KLRK1 [97]. Chicken is a key species because of its
‘‘minimal essential’’ MHC [98]. A family of chicken Ig-like
receptors (CHIRs) are related to Pirs and Fc receptors and are
arranged in similar genomic clusters to human KIR and LILR
genes [99]. Recent work has shown the presence of numerous
CHIR genes in the chicken genome, with many receptors
possessing both activating and inhibitory properties [100].
The multiple CHIR genes are thought to have emerged from a
common ancestor with humans before the mammalian
radiation and then expanded in a lineage-speciﬁc manner
[100,101]. There are examples of chicken NK receptors, such
as B-NK and N-lec, which contain C-type lectin domains,
similar to the NKC-encoded NKRP1 and LLT1 in humans. It
is interesting, though, that the genes encoding these proteins
are located within the chicken MHC region, consistent with
an ancient genetic relationship of these MHC and NK
receptors [102].
The zebraﬁsh, a teleost model organism, contains a cluster
of putative activating and inhibitory NK receptors called the
novel immune-type receptors (NITRs). While these genes
encode an Ig domain, there is a cluster of C-type lectins
encoded within this larger cluster [103,104]. Another bony
ﬁsh, Oreochromis niloticus, possesses a KLR region, containing
26 genes, though more compact than its human counterpart
[105]. Other teleosts have NKC genes, including
Paralabidochromis chilotes [106] and rainbow trout [107],
demonstrating that some of these genes arose in an ancestor
common to both humans and bony ﬁsh earlier in the
gnathostome lineage.
Conclusions
As explained above, features of NK receptor genes both
within and between species are consistent with rapid
evolutionary change. Inevitably, studies focus on human KIR
and mouse Ly49 genes, but there are indications from the few
studies of other vertebrates that variable C-type lectin and
IgSF receptors for MHC class I molecules may co-exist in a
species, such as horse [96], or may be functionally replaced by
another divergent family of genes, as may be the case in
chicken [100,101]. The marked expansion of the Ly49 gene
family [76] and the large differences in gene number and
content between closely related species, such as the mouse
and rat [108], attest to rapid evolution of NK receptor genes.
The existence of only one Ly49 pseudogene in humans [27]
while a homolog remains functional in other primates [44,60]
also indicates rapid evolutionary change since the divergence
of a common ancestor. It is possible that the presence of gene
families such as those found in the NK receptor complexes
facilitates rapid evolution through recombination,
subfunctionalization of duplicated genes, and conservation of
essential sequence [109].
Emerging data are also consistent with rapid evolution of
NKC-encoded genes. These include comparisons of KIR
haplotypes in chimpanzee, rhesus macaque, and human,
where, in addition to gene content differences, repeat
elements in intronic regions suggest rapid evolution [41].
Another recent report showed that the KIR and Ly49 gene
families have among the highest expansion rates in the
genome, with the human KIRs expanding by 0.52 genes per
million years and rat Ly49 genes expanding by 0.54 genes per
million years since duplicating from a single common
ancestor [76]. A more conservative study to determine the
genome-wide average for this rate found it to be 0.001 to 0.03
genes duplicated per million years [110]. Recent data indicate
that inhibitory KIRs are ancestral and that their activating
counterparts have evolved from them by mutation [111]. It
appears that the development of activating versions of
polymorphic receptors takes place in both KIR and Ly49 loci.
Thus, in different species, convergent evolution results in
PLoS Genetics | www.plosgenetics.org August 2005 | Volume 1 | Issue 2 | e27 0135activating genes with similar signaling domains. This
mechanism is necessitated so that the receptors can couple
with appropriate signaling adaptors (see Figure 1), which are
ancient and much more conserved than both KIR and Ly49.
The mechanism is streamlined, in that tails associated with
activating adapters become associated with different
receptors by nonhomologous recombination [19].
Interestingly, activating receptors appear to evolve
recurrently, presumably in line with selection associated with
resistance to disease.
Perhaps because of this ‘‘response mode’’ ﬂuctuation in
activating versions of inhibitory receptors, it has proved
difﬁcult to identify their role and indeed their ligands. An
interesting exception is mouse Ly49h, which recognizes
mCMV-infected cells by a direct interaction with the m157
mCMV gene product [84]. So far, no other activating
receptors appear to be dedicated to pathogen-speciﬁc
products. However, there is evidence for epistasis between
MHC class I loci and Ly49 in resistance to mCMV, which may
explain the difﬁculty in identifying ligands for activating
receptors [112]. Ly49p is an activating receptor that
speciﬁcally recognizes mCMV-infected cells but only in the
context of H-2Dk. Accordingly, binding of Ly49p was blocked
by antibodies to H-2Dk but not by those to H-2Kk. It is not
known what lies behind the epistasis. It is possible that Ly49p
recognizes H-2Dk only when certain viral peptides are
present. It has been proposed that in the case of another
receptor, Ly49c, certain peptides might exert interactions
through the ﬂoor of the H-2Kb binding groove, which are
transmitted to the NK receptor by b2 microglobulin [113].
Alternatively, NK receptors such as Ly49c and Ly49p might
respond to an H-2 molecule in the presence of a host-
encoded protein that is upregulated upon viral infection.
Intriguingly, similar mechanisms could be put forward to
explain the role of activating KIRs such as KIR2DS1 being
upregulated during Epstein-Barr virus infection [114].
Why do some species expand KIR genes while others
expand Ly49 genes? While these two gene families produce
proteins of analogous function, they do not share a common
ancestor. These expansions vary greatly even within lineages,
such as between human and chimpanzee (diverged
approximately 5 million years ago) or mouse and rat
(diverged approximately 20 million years ago) [115]. It is
tempting to assume that different life spans, environments,
sizes, and, speciﬁcally, pathogen interactions inﬂuence
ﬁxation of different NK receptor repertoires in different
species. NK receptors are important components of antiviral
immune responses and are an essential bridge between early
innate responses, such as the release of virally induced
interferon-alpha (IFNA) and interferon-beta (IFNB), and the
later T cell and antibody adaptive responses [116]. Viruses
evolve rapidly to environmental conditions, crossing species
boundaries and mutating quickly to allow success in speciﬁc
host species [117]. It is possible that the rapid evolution and
host-species-speciﬁc adaptations of viral pathogens, which
are common targets of NK-mediated immune responses,
could inﬂuence the rapid expansion of different NK receptor
repertoire combinations among species. Selective forces
other than infection may also be entertained, including
autoimmunity and reproduction, illustrated by the link
between preeclampsia and combinations of HLA-C in the
fetus and KIR in the mother [56].
NK receptor gene clusters coevolve with MHC genes [3,15],
and there are clues to genetic and functional relationships
between them [1]. MHC class I–like molecules have directed
the development of different lymphocytes throughout
evolution, as demonstrated both by the presence of common
cell surface markers on NK cells, cd T cells, and CD8
þ ab T
cells and by distinct receptors present exclusively on each
class [4]. The large differences in genomic organization of NK
receptor gene complexes between species, and between
populations of humans, are likely driven by resistance to
infection and exposure to different local pathogens [118,119],
although different mechanisms are possible [120]. Some
MHC-encoded genes maintain a large number of low-
frequency alleles within the population [118], produce
molecules that interact to control NK cell function, and
evolve rapidly to maintain their epistatic interactions [42]. Ig
domains provide an example of the way coevolution of these
interactions may occur. The Ig domains encoded by LRC
genes are IgC2 or vIg-like [121]. IgC2 domains appear to have
evolved to recognize different Ig-like receptors [15], such as
those found in the MHC, consistent with coevolution of some
LRC and MHC genes. Another example of coevolution
between NK receptor genes and MHC genes is provided by
the Mill gene family in mice and rats. The Mill family
members are functional homologs of human MIC genes,
which are found in the human MHC class I region. However,
in mice and rats, the Mill genes have translocated to a
chromosomal area near the LRC [87], which, through linkage
with NK receptor genes, could facilitate coevolution of
polymorphisms affecting their epistatic interactions and
enhance their transcriptional regulation. Furthermore, the
coevolution of NK receptors and HLA-C molecules, observed
in primates [44], could have implications for diseases [4,5] and
for the interactions between HLA-C molecules and decidual
NK receptors in the placenta [56].
Additional insights into the rapid coevolution of the NK
receptor genes and genes encoding their MHC class I ligands
can be gained by studying their levels of polymorphism.
Publicly available polymorphism data, evaluated in a previous
study from our laboratory [122], showed that MHC class I
molecules possess extremely high levels of polymorphism,
while the numbers of polymorphisms per kilobase for NK
receptor genes are nearer to values for the rest of the
genome. Although some NK receptor gene families have
noticeably varied gene contents between haplotypes, NK
receptor genes are not as highly polymorphic as MHC class I
ligands. Therefore, we could assume that selective pressures,
such as exposure to pathogen, drive the generation of genetic
variation primarily on MHC class I genes. The variation in NK
receptor gene content both within and between species, such
as preference towards rapid expansion of KIR, Ly49, or both,
could be a mechanism for coevolving with the rapidly
evolving MHC class I molecules. This would explain how NK
receptor gene complexes exhibit rapid evolution, measured
by parameters such as gene gain and loss [76], while having
moderate levels of sequence polymorphism. Given the
essential interactions of MHC and NK receptor gene clusters,
the high levels of polymorphism, and association of the MHC
with disease, studies of NK receptor gene complexes will have
to be interpreted in relation to their MHC ligands.
As more conﬁgurations of NK receptor genes are
determined for different species, it will become possible to
PLoS Genetics | www.plosgenetics.org August 2005 | Volume 1 | Issue 2 | e27 0136track the way groups of KIR and Ly49 loci have followed
different species lineages. Were rodents the only species to
lose KIR function? Are primates unique in losing Ly49? What
are the intermediates on the way to ‘‘all KIR’’ and ‘‘all Ly49’’
models? And what selective advantages drove the
specialization towards the KIR or Ly49 model in different
species? &
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